Our results, especially those showing increased activation markers' expression on the CD4+ cells of high responders from both healthy and AD groups, suggest that susceptibility towards activation induced by anti-CD3 combined with β-amyloid peptides is associated with initial activation status of CD4+ cells and not necessarily with presence of Alzheimer disease itself. The gene discussed is CD4; the disease is Alzheimer disease.